Ipca Laboratories' Board has proposed a final dividend of Rs. 6/- per equity share (600%) for the financial year.

This significant payout, subject to shareholder approval at the upcoming Annual General Meeting, underscores the company's robust performance.

A record date has been set for eligible shareholders.

This move is expected to positively impact shareholder returns and demonstrates management's commitment to delivering value to investors.